Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
Martelli M, Gherlinzoni F, De Renzo A, Zinzani PL, De Vivo A, Cantonetti M, Falini B, Storti S, Meloni G, Rizzo M, Molinari AL, Lauria F, Moretti L, Lauta VM, Mazza P, Guardigni L, Pescarmona E, Pileri SA, Mandelli F, Tura S. Martelli M, et al. Among authors: cantonetti m. J Clin Oncol. 2003 Apr 1;21(7):1255-62. doi: 10.1200/JCO.2003.01.117. J Clin Oncol. 2003. PMID: 12663712 Clinical Trial.
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease.
Aglietta M, Montemurro F, Fagioli F, Volta C, Botto B, Cantonetti M, Racanelli V, Teofili L, Ferrara R, Amadori S, Castoldi GL, Dammacco F, Levis A. Aglietta M, et al. Among authors: cantonetti m. Cancer. 2000 Jan 15;88(2):454-60. doi: 10.1002/(sici)1097-0142(20000115)88:2<454::aid-cncr28>3.0.co;2-q. Cancer. 2000. PMID: 10640980 Clinical Trial.
Vitamin D and non-Hodgkin lymphomas, trends from an Italian monocentric study.
Postorino M, Massoud R, Guarnera L, Meddi E, Vacros G, LA Manna M, Rapisarda VM, Zizzari A, Perrone A, Tesei C, Giammatteo J, Marsella LT, Del Poeta G, Hohaus S, Cantonetti M. Postorino M, et al. Among authors: cantonetti m. Panminerva Med. 2021 Dec;63(4):547-549. doi: 10.23736/S0031-0808.21.04501-8. Panminerva Med. 2021. PMID: 34915692 No abstract available.
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.
Del Poeta G, Del Principe MI, Consalvo MA, Maurillo L, Buccisano F, Venditti A, Mazzone C, Bruno A, Gianní L, Capelli G, Lo Coco F, Cantonetti M, Gattei V, Amadori S. Del Poeta G, et al. Among authors: cantonetti m. Cancer. 2005 Dec 15;104(12):2743-52. doi: 10.1002/cncr.21535. Cancer. 2005. PMID: 16284990 Free article. Clinical Trial.
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors.
Bruno A, Caravita T, Adorno G, Del Poeta G, Venditti A, Stasi R, Ballatore G, Del Proposto G, Lanti A, Zinno F, Cudillo L, Dentamaro T, Buccisano F, Tamburini A, Santinelli S, Maurillo L, Cantonetti M, Cox MC, Masi M, Catalano G, Isacchi G, Amadori S. Bruno A, et al. Among authors: cantonetti m. Transfus Apher Sci. 2002 Apr;26(2):103-10. doi: 10.1016/s1473-0502(01)00157-4. Transfus Apher Sci. 2002. PMID: 12121064
[Recent biological and therapeutic advances in multiple myeloma].
Coppetelli U, Avvisati G, Tribalto M, Cantonetti M, La Verde G, Petrucci T, Stasi R, Papa G. Coppetelli U, et al. Among authors: cantonetti m. Recenti Prog Med. 1992 Sep;83(9):520-7. Recenti Prog Med. 1992. PMID: 1439122 Review. Italian.
116 results